The healing power of cannabis.

Welcome to Blissco. Conscious plant derived healthcare free from the long-term effects of toxins, unnecessary chemicals and pesticides. We partner with medical experts, naturopaths, and passionate green thumbs. Whether helping your body heal, or shifting perspective, cannabis has opened doors for humanity over the millennia.

Whole flower. Whole you.



It’s not the destination, it’s the journey.

We love sharing the joy of anticipation, and there is nothing more thrilling than rising up and looking forward to something new and exciting. Here are a few things we have in the works:



Pre-registration for New Patients

For a limited time only, when you pre-register as a Blissco client you will receive a complimentary Cooking Journal. For information regarding registration or our line of premium cannabis products, you can reach our dedicated Client Care Specialists between 9:00am and 5:00pm PST Monday-Friday at 1-877-310-2547(BLIS) or by emailing


New E-Commerce Site is launching soon and will be fully operational for registered clients to order an abundance of whole flower cannabis products, including dried cannabis and cannabis oil.

New Blissconnect Telemedicine App

Blissconnect, our new telemedicine app is launching soon and will provide free and convenient consultations with nurse practitioners for medical cannabis - right from the comfort of your own home.

New Investor Site

Our investor relations site is launching soon and will give new and current investors access to resources and investment updates.

Frequently Asked Questions

We’re always happy to help.

How can we support you on your wellness journey? Our Client Care Team is ready to answer any questions you may have. You can reach our dedicated Client Care Specialists between 9:00am and 5:00pm PST Monday-Friday at 1-877-310-2547(BLIS) or by emailing


Is Blissco Licensed?

Yes. Blissco is federally licensed by Health Canada as a producer and distributor of medical dried cannabis. In addition, Blissco is licensed to produce cannabis oil in its' extraction lab. Registering with and purchasing from us ensures you are obtaining your medical cannabis in full accordance with federal regulations. Our license status can be confirmed on Health Canada’s website here.

How do I obtain my prescription for medical cannabis?

You will be able to speak directly to a medical doctor or nurse practitioner through Blissconnect, our free telemedicine app service (launching soon), or through your current doctor.

How can I purchase cannabis with Blissco?

Once our e-commerce website launches, you will be able to log into with your unique Client ID or speak with our Client Care Team to place your order.

What forms of payment do you accept?

We will accept Visa, MasterCard, Visa Debit and MasterCard Debit.  

How do you ship your orders?

We will ship our premium products through Canada Post and Purolator.

For Investors

Contact Information

(604) 484-9119

Stock Information

Canadian Stock Exchange (CSE) as Blissco Cannabis Corp. (BLIS)

OTCQB as Blissco Cannabis Corp (HSTRF)

Frankfurt Stock Exchange (FRA) as Blissco Cannabis Corp. (GQ4B:GR)

Financial Information


Q3 2019 Financial Statement, MD&A. To access a replay of the earnings conference call please dial 1-800-319-6413, Code: 2836.

Q2 2019 Financial Statement, MD&A.

Q1 2019 Financial Statement, MD&A.


2018 Jan 31 Year End Statement Statement.


Press Releases & News

March 18 - Blissco Signs Supply Agreement with Alberta Gaming, Liquor and Cannabis (AGLC)

March 8 - Blissco Ships Initial Order to BC Liquor Distribution Branch

March 7 - Blissco Receives Positive European Union Good Manufacturing Practices Inspection Report

February 27 - Blissco Selected to Present at Sick Kids Hospital on Canadian Childhood Cannabinoid Clinical Trials

February 14 - Blissco Expands Leadership & Executive Team to Accelerate National & International Growth Strategy

February 13 - Blissco Earns DTC Eligibility for Increased Access to U.S. Investors

February 6 - Blissco CEO Interviewed by Steve Darling of Proactive Investors Limited

January 17 - Blissco to Supply Saskatchewan Retailers with Premium Cannabis

January 11 - Blissco Signs Distribution Agreement with Pharmadrug in Germany

January 8 - A New Years Message from the CEO

December 21 - Blissco Announces Q3 2019 Financial Results.

Note: A telephone replay of the Q3 Financial Results will be available December 21, 2018 to January 21, 2019 by dialling 1-800-319-6413, access code: 2836.

December 20 - Blissco Signs Supplier Agreement & Receives Initial Purchase Orders from BC Liquor Distribution Branch

December 12 – Blissco Announces Q3 2019 Financial Results Conference Call

November 16 – BlissCo Receives Cannabis Sales License from Health Canada, Press Release

October 24, 2018 – BlissCo Announces the appointment of Meena Ballantyne to it's board of director

October 22, 2018 – BlissCo Appoints New CFO to Take Company Through Next Phase of Growth

October 17, 2018 – BlissCo CEO Featured as Cannabis Expert on Breakfast Television, Global News and More

September 25, 2018 – BlissCo Completes Pre-Sales License Inspection

September 21, 2018 – BlissCo Cannabis Corp. Now Trading on the OTCQB as HSTRF

September 13, 2018 – BlissCo Signs Agreement to Offer Same-day Delivery of Medical Cannabis

September 4, 2018 – BlissCo Earns Pre-Sales License Inspection from Health Canada

August 22, 2018 – BlissCo Prepares for Revenue

August 13, 2018 – Health Canada Grants Cannabis Oil Production License Amendment to BlissCo

August 9, 2018 – BlissCo Hires Experienced Clinic Leader to Drive Revenue with Patient Care and Call Center Programs

August 2, 2018 – BlissCo CEO to Deliver Expert Keynote Presentation at Cannabis Business Europe 2018; Accelerates Expansion of Domestic and Global Ecosystem

July 26, 2018 – BlissCo One Step Closer to Medical Cannabis Exports to Germany

July 18, 2018 – BlissCo Signs Artificial Intelligence E-Commerce and Technology Agreement with Namaste to Serve Billion Dollar Cannabis E-Commerce Market

July 12, 2018 – BlissCo Ecosystem Continues Expansion: Signs Base Price and Profit Sharing Supply Agreement with GreenSeal

June 29, 3018 – BlissCo Reports First Quarter 2018 Financial Results: Fully Capitalized for Expansion with $3.3M to Continue Growing its Global Cannabis Ecosystem

June 25, 2018 – BlissCo Receives Dried Cannabis From Ecosystem Partner Supreme for Sales License Amendment Application to Serve $200 Billion Medical Export Market

June 22, 2018 – Canada Legalizes Recreational Cannabis - BlissCo Ready to Bloom

June 21, 2018 – BlissCo Enters Europe with LOI for Cannabis Sales in Germany

June 20, 2018 – BlissCo Enters Billion-Dollar Complementary and Alternative Medicine Market, Appoints Dr. Bryn Hyndman to Advisory Board

June 13, 2018 – BlissCo Cannabis Corp Announces License Amendment Application to Produce Cannabis Oil

May 31, 2018 – BlissCo Cannabis Corp Announces Listing on Frankfurt Stock Exchange

May 23, 2018 – BlissCo Cannabis Corp Provides Corporate Update

May 7, 2018 – BlissCo Cannabis Corp Receives its Cultivars at its Langley Facility

May 3, 2018 – BlissCo Cannabis Changes Auditor to MNP LLP & Options Cancelled

April 12, 2018 – BlissCo Earns Occupancy Permit from Township of Langley

April 2, 2018 – Health Canada grants Cannabis Cultivation Licence to BlissCo

March 06, – BlissCo Completes Oversubscribed Raise of$5.6M and Secures Supply to Accelerate 2018 Growth

March 02, 2018 – CSE New Listing – BlissCo Cannabis Corp. (BLIS)

March 02, 2018 – BlissCo Completes Acquisition and Closes Over-Subscribed Financing

February 26, 2018 – Supreme makes strategic investment in distribution partner and secures supply agreement with BlissCo